NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8404
-0.0256 (-2.96%)
At close: Mar 9, 2026, 4:00 PM EDT
0.8800
+0.0396 (4.71%)
After-hours: Mar 9, 2026, 7:58 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $28.07 million as of March 9, 2026. Its market cap has increased by 9.84% in one year.
Market Cap
28.07M
Enterprise Value
28.31M
1-Year Change
9.84%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $28.07M, a decrease of -56.56%. That is a compound annual growth rate of -17.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 28.92M | 26.63% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 31.55M |
| NovaBay Pharmaceuticals | 30.04M |
| Tevogen Bio Holdings | 29.96M |
| Kyntra Bio | 29.55M |
| RenovoRx | 29.32M |
| Lantern Pharma | 29.19M |
| Dyadic International | 28.26M |
| Hyperion DeFi | 27.96M |